1. Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI. Issue 1 (December 2018) Authors: Ina Ly, K.; Vakulenko-Lagun, Bella; Emblem, Kyrre; Ou, Yangming; Da, Xiao; Betensky, Rebecca; Kalpathy-Cramer, Jayashree; Duda, Dan; Jain, Rakesh; Chi, Andrew; Plotkin, Scott; Batchelor, Tracy; Sorensen, Gregory; Rosen, Bruce; Gerstner, Elizabeth Journal: Scientific reports Issue: Volume 8:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. NIMG-66. LONG-TERM FOLLOW-UP OF NEUROFIBROMATOSIS TYPE 1 PATIENTS USING WHOLE-BODY MRI DEMONSTRATES DYNAMIC CHANGES IN INTERNAL NEUROFIBROMA SIZE. (11th November 2019) Authors: Ly, Ina; Thalheimer, Raquel; Cai, Wenli; Bredella, Miriam; Merker, Vanessa; Plotkin, Scott; Jordan, Justin Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ACTR-36. A SINGLE ARM PHASE 2 STUDY OF THE DUAL mTORC1/mTORC2 INHIBITOR VISTUSERTIB PROVIDED ON AN INTERMITTENT SCHEDULE FOR NEUROFIBROMATOSIS 2 PATIENTS WITH PROGRESSIVE OR SYMPTOMATIC MENINGIOMAS. (5th November 2018) Authors: Plotkin, Scott; Jordan, Justin; Beauchamp, Roberta; Muzikansky, Alona; Stemmer-Rachamimov, Anat; Ramesh, Vijaya Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. NFM-09. PRELIMINARY REPORT OF A MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY. Issue 2 (22nd June 2018) Authors: Tonsgard, James; Ullrich, Nicole; Blakeley, Jaishri; Rosser, Tena; Packer, Roger; Korf, Bruce; Fisher, Michael; Cutter, Gary; Plotkin, Scott; Karajannis, Matthias; Allen, Jeffrey; Wade Clapp, D; Thomas, Coretta; Campian, Jian Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. NFM-06. NF106: PHASE 2 TRIAL OF THE MEK INHIBITOR PD-0325901 IN ADOLESCENTS AND ADULTS WITH NF1-RELATED PLEXIFORM NEUROFIBROMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY. Issue 2 (22nd June 2018) Authors: Weiss, Brian; Plotkin, Scott; Widemann, Brigitte; Tonsgard, James; Blakeley, Jaishri; Allen, Jeffrey; Schorry, Elizabeth; Korf, Bruce; Rosser, Tena; Goldman, Stewart; Vinks, Alexander; Cutter, Gary; Dombi, Eva; Ratner, Nancy; Packer, Roger; Fisher, Michael Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. NFM-06. NF106: PHASE 2 TRIAL OF THE MEK INHIBITOR PD-0325901 IN ADOLESCENTS AND ADULTS WITH NF1-RELATED PLEXIFORM NEUROFIBROMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY. Issue 2 (22nd June 2018) Authors: Weiss, Brian; Plotkin, Scott; Widemann, Brigitte; Tonsgard, James; Blakeley, Jaishri; Allen, Jeffrey; Schorry, Elizabeth; Korf, Bruce; Rosser, Tena; Goldman, Stewart; Vinks, Alexander; Cutter, Gary; Dombi, Eva; Ratner, Nancy; Packer, Roger; Fisher, Michael Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. NFM-01. NF105: A PHASE II PROSPECTIVE STUDY OF CABOZANTINIB (XL184) FOR PLEXIFORM NEUROFIBROMAS IN SUBJECTS WITH NEUROFIBROMATOSIS TYPE 1: A NEUROFIBROMATOSIS CLINICAL TRIAL CONSORTIUM (NFCTC) STUDY. Issue 2 (22nd June 2018) Authors: Shih, Chie-Schin; Blakely, Jaishri; Clapp, Wade; Wolters, Pam; Dombi, Eva; Cutter, Gary; Ullrich, Nichole; Allen, Jeffrey; Packer, Roger; Goldman, Stewart; Gutmann, David; Plotkin, Scott; Rosser, Tena; Robertson, Kent; Widemann, Brigitte; Korf, Bruce; Fisher, Michael Journal: Neuro-oncology Issue: Volume 20:Issue 2(2018)supplement 2 Page Start: i142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. ACTR-09. A PHASE 0 PHARMACODYNAMIC AND PHARMACOKINETIC STUDY OF EVEROLIMUS IN VESTIBULAR SCHWANNOMA (VS) AND MENINGIOMA PATIENTS. (11th November 2019) Authors: Karajannis, Matthias; Goldberg, Judith; Thomas Roland, J; Sen, Chandranath; Placantonakis, Dimitris; Golfinos, John; Allen, Jeffrey; Dunbar, Erin; Plotkin, Scott; Akshintala, Srivandana; Schneider, Robert; Deng, Jingjing; Neubert, Thomas A; Giancotti, Filippo; Zagzag, David; O Blakeley, Jaishri Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. INNV-04. A MULTI-INSTITUTIONAL CLINICAL AND MRI REPOSITORY OF NEUROFIBROMATOSIS TYPE 1-ASSOCIATED PERIPHERAL NERVE SHEATH TUMORS. (12th November 2021) Authors: Ly, Ina; Hirbe, Angela; Jordan, Justin; Michaels, Olivia; Kwon, Daniel; Borcherding, Dana; Srihari, Divya; Dombi, Eva; Widemann, Brigitte; Pollard, Kai; Pratilas, Christine; Boswell, Demetrius; de Blank, Peter; Melecio-Vázquez, Mairim; Chi, Ping; Salamon, Johannes; Mautner, Viktor; Mulder, Zachar... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. CTNI-17. A PHASE 1 WITH DOSE EXPANSION/PHASE 2 STUDY OF SELINEXOR IN COMBINATION WITH STANDARD OF CARE THERAPY FOR NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA. (12th November 2021) Authors: Odia, Yazmin; Wen, Patrick; Mehta, Minesh; Colman, Howard; Dunbar, Erin; Butowski, Nicholas; Harrison, Rebecca; Schulder, Michael; Boockvar, John; Chow, Frances; Kumthekar, Priya; Mason, Warren; Venur, Vyshak; Plotkin, Scott; Lassman, Andrew; Duic, Paul; Tamir, Sharon; Li, Kai; Liu, Yang; Mundy, ... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗